NCT03887884View on ClinicalTrials.gov

Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

June 28, 2019

Study Completion Date

June 28, 2019

Conditions
Parkinson's Disease
Interventions
DRUG

CVT-301

Levodopa Inhalation Powder

DRUG

Sinemet

Single oral dose of Carbidopa/Levodopa 25 mg/100 mg

Trial Locations (5)

30331

Acorda Site #1004, Atlanta

32806

Acorda Site #1002, Orlando

33009

Acorda Site #1005, Hallandale

48334

Acorda Site #1001, Farmington Hills

90806

Acorda Site #1003, Long Beach

Sponsors
All Listed Sponsors
lead

Acorda Therapeutics

INDUSTRY